|
2012
|
Invention
|
Crystal forms of 2--adenosine.
The present invention provides novel crystalline polymorphic form... |
|
|
Invention
|
Allosteric enhancers of th a1 adenosine receptor.
The present invention provides compounds of fo... |
|
2009
|
Invention
|
Methods of treating atherosclerosis.
The present invention relates to adenosine A2B receptor ant... |
|
|
Invention
|
Methods of treating atherosclerosis. The present invention relates to adenosine A3 receptor antag... |
|
|
Invention
|
Methods of treating atherosclerosis. The present invention relates to adenosine A2B receptor anta... |
|
|
Invention
|
Allosteric enhancers of the a1 adenosine receptor. The present invention provides compounds of fo... |
|
|
Invention
|
Allosteric enhancers of the a1 adenosine receptor.
The present invention provides compounds of f... |
|
|
Invention
|
Crystal forms of 2-{2-[(cyclohexyl)methylene]hydrazino}adenosine. The present invention provides ... |
|
2008
|
Invention
|
Crystal forms of 2-[2-(4-chlorophenyl)ethoxy]adenosine.
The present invention provides novel cry... |
|
|
Invention
|
Crystal forms of 2-[2-(4-chlorophenyl)ethoxy]adenosine. The present invention provides novel crys... |
|
|
Invention
|
Crystals of (2-amino-4,5,6,7-tetrahydrobenzo[b]thien-3-yl)(4-chlorophenyl)methanone. The present ... |
|
|
Invention
|
Crystals of (2-amino-4,5,6,7-tetrahydrobenzo[b]thien-3-yl)(4-chlorophenyl)methanone.
The presen... |
|
|
Invention
|
Pharmaceutical compositions for the treatment of pain. The present invention provides pharmaceuti... |
|
|
Invention
|
Pharmaceutical compositions for the treatment of pain.
The present invention provides pharmaceut... |
|
|
Invention
|
Methods of treating hypertension. The present invention is directed to pharmaceutical composition... |
|
|
Invention
|
Adenosine a2a receptor antagonists. The present invention provides compounds of the formula (I) w... |
|
|
Invention
|
2a receptor activity. The present invention provides compounds of the formula
2A receptor activi... |
|
|
Invention
|
2a receptor antagonists. The present invention provides compounds of the formula
2A receptor act... |
|
2007
|
Invention
|
Allosteric modulators of the a1 adenosine receptor. The present invention provides compounds of f... |
|
|
Invention
|
1 adenosine receptor. The present invention provides compounds of formula (I)
1 adenosine recept... |
|
|
Invention
|
Compositions and methods for improving the bioavailability of liothyronine. The present invention... |
|
|
Invention
|
Combination therapy for the treatment of pain. The present invention provides synergistic combina... |
|
|
Invention
|
Combination therapy for the treatment of pain.
The present invention provides synergistic combin... |
|
|
Invention
|
Adenosine a3 receptor modulators. The compounds of the following formula:
3 receptors.
|
|
|
Invention
|
Adenosine a2b receptor antagonists. The present invention provides compounds of the formula (I) w... |
|
|
Invention
|
Adenosine a2b receptor antagonists. The present invention provides compounds of the formula
2B r... |
|
|
Invention
|
2b receptor agonists. The present invention provides compounds of the formula
2B receptor includ... |
|
|
Invention
|
Combination therapy comprising an adenosine uptake inhibitor and a non-selective adenosine recept... |
|
|
Invention
|
Pharmaceutical compositions for promoting wound healing. The present invention relates to pharmac... |
|
|
Invention
|
Pharmaceutical compositions for promoting wound healing.
The present invention relates to pharma... |
|
2006
|
Invention
|
Pharmaceutically active compounds and methods of use. New fused thiophene compounds are provided ... |
|
|
Invention
|
Controlled release pharmaceutical compositions of liothyronine and methods of making and using th... |
|
|
Invention
|
2b receptor antagonists. The present invention relates generally to compounds of formula (I):
2 ... |
|
|
Invention
|
Novel adenosine a3 receptor modulators. A class of novel antagonists for the adenosine A3 recepto... |
|
|
Invention
|
3 receptor modulators. 3 receptor. |
|
2005
|
Invention
|
Oxygen-impervious packaging and methods for storing thyroid hormone. Novel packaging, methods of ... |
|
|
Invention
|
3 receptor modulators. The compounds of the following formula:
3 receptors.
|
|
|
Invention
|
Synthesis of 2-aralkyloxyadenosines, 2-alkoxyadenosines, and their analogs. Provided is a method ... |
|
2004
|
Invention
|
3 receptor agonists. The compounds of the following formula:
1 have the meanings given in the sp... |
|
2000
|
P/S
|
Oral opioid used in humans for the treatment of pain. |
|
1992
|
P/S
|
[ veterinary pharmaceutical preparations; namely, urinary acidifiers, bacterial enteritis and dia... |
|
1989
|
P/S
|
Pharmaceutical preparations for cardiac disorders. |
|
1951
|
P/S
|
A medicinal preparation of dibenzylethylenediamine dipenicillin. |
